|Articles|December 12, 2019
Almac Group and Exostar Collaborate
Advertisement
Almac Clinical Technologies, a member of the Almac Group, has announced the launch of an integration between its Interactive Response Technology platform-IXRS 3, and Exostar’s Identity and Access Management Platform.
To learn more about the collaboration, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5